Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]

104 reported adverse events

Drugs of this class: TECOVIRIMAT MONOHYDRATE

These side effects are most commonly reported by patients taking drugs of the Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] class:

# Side effect Count
0 DRUG RESISTANCE 19
1 HEADACHE 14
2 NAUSEA 14
3 FATIGUE 12
4 DIARRHOEA 10
5 ACUTE KIDNEY INJURY 6
6 ALANINE AMINOTRANSFERASE INCREASED 6
7 DECREASED APPETITE 5
8 OFF LABEL USE 5
9 ABDOMINAL PAIN 4
See all common reactions for Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]

Drugs of the Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VACCINATION SITE INJURY 1 0.1111
1 PROTEIN ALBUMIN RATIO DECREASED 1 0.0455
2 MONKEYPOX 3 0.0109
3 DRUG RESISTANCE MUTATION 1 0.0056
4 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 1 0.0026
5 BLOOD BICARBONATE INCREASED 1 0.0021
6 BLOOD BILIRUBIN DECREASED 1 0.0016
7 MONOCYTOSIS 1 0.0016
8 SUPERINFECTION BACTERIAL 1 0.0013
9 PERITONSILLAR ABSCESS 1 0.0012
See all enriched reactions for Orthopoxvirus VP37 Envelope Wrapping Protein Inhibitor [EPC]